Haemochromatosis and neuromuscular complaints - A prospective clinical study

Haemochromatosis and neuromuscular complaints - A prospective clinical study - Haemochromatosis and neuromuscular complaints

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30114

Enrollment

Registered

2006-10-12

Start date

2007-02-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

haemochromatosis iron storage disorder

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age 18 years or older - definite diagnosis of haemochromatosis: i.e., (a) Transferrin saturation in fasting state > 45 % AND (b) Homozygosity for C282Y or compound heterozygosity C282Y/H63D - informed written consent before entering the study

Exclusion criteria

Exclusion criteria: - unable to read and understand the questionnaires (in Dutch) - unable to follow-up

Design outcomes

Primary

Measure	Time frame
Evidence of a neuromuscular disorder (e.g., neuropathy or myopathy). Cause of this neuromuscular disorder. Prevalance of neuromuscular symptoms and signs. The impact of neuromuscular symptoms and signs on the quality of life.	—

Countries

Netherlands

Outcome results